Sci Pharmtech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 07, 2021 at 05:23 am IST
Share
SCI Pharmtech, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 176.572 million compared to TWD 727.922 million a year ago. Operating income was TWD 5.401 million compared to TWD 295.200 million a year ago. Net income was TWD 3.751 million compared to TWD 241.670 million a year ago. Basic earnings per share from continuing operations was TWD 0.05 compared to TWD 3.04 a year ago. Diluted earnings per share from continuing operations was TWD 0.05 compared to TWD 3.03 a year ago. For the half year, sales was TWD 500.198 million compared to TWD 1,512.250 million a year ago. Operating income was TWD 62.755 million compared to TWD 575.402 million a year ago. Net income was TWD 45.424 million compared to TWD 450.001 million a year ago. Basic earnings per share from continuing operations was TWD 0.57 compared to TWD 5.66 a year ago. Diluted earnings per share from continuing operations was TWD 0.57 compared to TWD 5.62 a year ago.
SCI Pharmtech, Inc. is a Taiwan-based company principally engaged in the processing, manufacture and sales of Active Pharmaceutical Ingredients (APIs). The Company's main products include APIs, API intermediates and special and precision chemicals. The Company distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
SCI PHARMTECH, INC. 